Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6769930
[patent_doc_number] => 20030215870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Isolated and purified 12R-lipoxygenase polypeptide and polynucleic acid encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/445484
[patent_app_country] => US
[patent_app_date] => 2003-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21791
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10445484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/445484 | Isolated and purified 12R-lipoxygenase polypeptide and polynucleic acid encoding the same | May 26, 2003 | Abandoned |
Array
(
[id] => 7448996
[patent_doc_number] => 20040009946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Modulation of PTP1B expression and signal transduction by RNA interference'
[patent_app_type] => new
[patent_app_number] => 10/444925
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 27367
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009946.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444925
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444925 | Modulation of PTP1B expression and signal transduction by RNA interference | May 22, 2003 | Abandoned |
Array
(
[id] => 7363486
[patent_doc_number] => 20040014957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Oligonucleotides having modified nucleoside units'
[patent_app_type] => new
[patent_app_number] => 10/444628
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71178
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444628 | Oligonucleotides having modified nucleoside units | May 22, 2003 | Abandoned |
60/651504 | Oligonucleotide compositions and methods for the modulation of the expression of B7 protein | May 22, 2003 | Pending |
Array
(
[id] => 7358496
[patent_doc_number] => 20040014108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Oligonucleotides having modified nucleoside units'
[patent_app_type] => new
[patent_app_number] => 10/444298
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50598
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444298 | Oligonucleotides having modified nucleoside units | May 22, 2003 | Abandoned |
Array
(
[id] => 6725541
[patent_doc_number] => 20030207853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Cholesterol and hedgehog signaling'
[patent_app_type] => new
[patent_app_number] => 10/442435
[patent_app_country] => US
[patent_app_date] => 2003-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11510
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10442435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/442435 | Cholesterol and hedgehog signaling | May 19, 2003 | Issued |
Array
(
[id] => 7445666
[patent_doc_number] => 20040009602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'DNA modifying molecules and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/438076
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26986
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009602.pdf
[firstpage_image] =>[orig_patent_app_number] => 10438076
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/438076 | DNA modifying molecules and methods of use thereof | May 12, 2003 | Abandoned |
Array
(
[id] => 7251879
[patent_doc_number] => 20050074760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Enzymatic nucleic acids containing 5\'-and/or 3\'-cap structures'
[patent_app_type] => utility
[patent_app_number] => 10/430562
[patent_app_country] => US
[patent_app_date] => 2003-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19968
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10430562
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/430562 | Enzymatic nucleic acids containing 5'-and/or 3'-cap structures | May 5, 2003 | Abandoned |
Array
(
[id] => 7310614
[patent_doc_number] => 20040142946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Modified nucleosides and nucleotides and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/399951
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7910
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142946.pdf
[firstpage_image] =>[orig_patent_app_number] => 10399951
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/399951 | Modified nucleosides and nucleotides and use thereof | Apr 22, 2003 | Abandoned |
Array
(
[id] => 5738470
[patent_doc_number] => 20060008861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Incorporation of anaerobic bacteria in feed formulation'
[patent_app_type] => utility
[patent_app_number] => 10/511202
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1795
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511202
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511202 | Incorporation of anaerobic bacteria in feed formulation | Apr 13, 2003 | Abandoned |
Array
(
[id] => 6821710
[patent_doc_number] => 20030219871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Host cells having improved cell survival properties and methods to generate such cells'
[patent_app_type] => new
[patent_app_number] => 10/402017
[patent_app_country] => US
[patent_app_date] => 2003-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23616
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10402017
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/402017 | Host cells having improved cell survival properties and methods to generate such cells | Mar 27, 2003 | Abandoned |
Array
(
[id] => 7224446
[patent_doc_number] => 20040072743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Pharmaceutical composition of modified pna molecules'
[patent_app_type] => new
[patent_app_number] => 10/240641
[patent_app_country] => US
[patent_app_date] => 2003-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8790
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072743.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240641 | Pharmaceutical composition of modified pna molecules | Mar 20, 2003 | Abandoned |
Array
(
[id] => 7348640
[patent_doc_number] => 20040248296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'HIV therapeutic'
[patent_app_type] => new
[patent_app_number] => 10/393411
[patent_app_country] => US
[patent_app_date] => 2003-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19474
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10393411
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/393411 | HIV therapeutic | Mar 19, 2003 | Abandoned |
Array
(
[id] => 6796909
[patent_doc_number] => 20030175783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Methods and means for monitoring and modulating gene silencing'
[patent_app_type] => new
[patent_app_number] => 10/385546
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11244
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10385546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/385546 | Methods and means for monitoring and modulating gene silencing | Mar 11, 2003 | Abandoned |
Array
(
[id] => 7470226
[patent_doc_number] => 20040121348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Compositions and methods for treating pancreatic cancer'
[patent_app_type] => new
[patent_app_number] => 10/384434
[patent_app_country] => US
[patent_app_date] => 2003-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10200
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121348.pdf
[firstpage_image] =>[orig_patent_app_number] => 10384434
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/384434 | Compositions and methods for treating pancreatic cancer | Mar 6, 2003 | Abandoned |
Array
(
[id] => 81803
[patent_doc_number] => 07745417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Nucleosides or nucleotides having novel unnatural bases and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/521454
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 19
[patent_no_of_words] => 16396
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745417.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521454 | Nucleosides or nucleotides having novel unnatural bases and use thereof | Feb 27, 2003 | Issued |
Array
(
[id] => 6740775
[patent_doc_number] => 20030158144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Antisense modulation of estrogen receptor beta expression'
[patent_app_type] => new
[patent_app_number] => 10/376566
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27686
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158144.pdf
[firstpage_image] =>[orig_patent_app_number] => 10376566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/376566 | Antisense modulation of estrogen receptor beta expression | Feb 26, 2003 | Abandoned |
Array
(
[id] => 7436186
[patent_doc_number] => 20040002465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Polyene macrolide derivatives, use for vectoring molecules'
[patent_app_type] => new
[patent_app_number] => 10/373195
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10920
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002465.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373195 | Polyene macrolide derivatives, use for vectoring molecules | Feb 25, 2003 | Abandoned |
Array
(
[id] => 7136759
[patent_doc_number] => 20050181485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Cellulose digesting enzyme gene and utilization of the gene'
[patent_app_type] => utility
[patent_app_number] => 10/505474
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25383
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181485.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505474 | Cellulose digesting enzyme gene and utilization of the gene | Feb 24, 2003 | Abandoned |
Array
(
[id] => 7020040
[patent_doc_number] => 20050222059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Egfrviii specific monoclonal antibody and egfrviii ribozymes and use to detect, treat or prevent egfrviii associated cancer'
[patent_app_type] => utility
[patent_app_number] => 10/505591
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13445
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505591 | Egfrviii specific monoclonal antibody and egfrviii ribozymes and use to detect, treat or prevent egfrviii associated cancer | Feb 24, 2003 | Abandoned |